Prospect of immunotherapy combined with anti-angiogenic agents in patients with advanced non-small cell lung cancer

por Liang, Hongge, Wang, Mengzhao
Publicado 2019

MET Oncogene in Non-Small Cell Lung Cancer: Mechanism of MET Dysregulation and Agents Targeting the HGF/c-Met Axis

por Liang, Hongge, Wang, Mengzhao
Publicado 2020

Immunotherapy combined with epidermal growth factor receptor-tyrosine kinase inhibitors in non-small-cell lung cancer treatment

por Liang, Hongge, Liu, Xiaoyan, Wang, Mengzhao
Publicado 2018

Patterns of response in metastatic NSCLC during PD‐1 or PD‐L1 inhibitor therapy: Comparison of the RECIST 1.1 and iRECIST criteria

por Liang, Hongge, Xu, Yan, Chen, Minjiang, Zhong, Wei, Wang, Mengzhao, Zhao, Jing
Publicado 2020

A Novel c-Mesenchymal-Epithelial Transition Factor Intergenic Fusion Response to Crizotinib in a Chinese Patient With Lung Adenocarcinoma: A Case Report

por Liang, Hongge, Zhou, Dexun, Dai, Lin, Zhang, Moqin, Gao, Zhancheng, Mu, Xinlin
Publicado 2021

Prognostic impact of maximum standardized uptake value on (18)F‐FDG PET/CT imaging of the primary lung lesion on survival in advanced non‐small cell lung cancer: A retrospective st...

por Qiu, Xiaoling, Liang, Hongge, Zhong, Wei, Zhao, Jing, Chen, Minjiang, Zhu, Zhaohui, Xu, Yan, Wang, Mengzhao
Publicado 2021

Elevated levels of pre-treatment lactate dehydrogenase are an unfavorable predictor factor in patients with EML4-ALK rearrangement non-small cell lung cancer treated with crizotini...

por Liang, Hongge, Ma, Di, Xu, Yan, Zhao, Jing, Chen, Minjiang, Liu, Xiaoyan, Zhong, Wei, Li, Junling, Wang, Mengzhao
Publicado 2019

Clinicopathological characteristics of lung cancer in patients with systemic sclerosis

por Chen, Minjiang, Liu, Xiaoyan, Xu, Yan, Zhou, Qing, Shi, Yuequan, Zhang, Dongming, Liang, Hongge, Zhao, Jing, Zhong, Wei, Wang, Mengzhao
Publicado 2020

Prognostic Factors and Survival Benefits of Antitumor Treatments for Advanced Non-Small Cell Lung Cancer Patients With Central Nervous System Metastasis With or Without Driver Gene...

por Gao, Xiaoxing, Chen, Minjiang, Liu, Xiaoyan, Shi, Yuequan, Liang, Hongge, Zhou, Qing, Zhao, Jing, Pan, Ruili, Zhong, Wei, Xu, Yan, Wang, Mengzhao
Publicado 2022

Characterization of Somatic Mutations That Affect Neoantigens in Non-Small Cell Lung Cancer

por Liang, Hongge, Xu, Yan, Chen, Minjiang, Zhao, Jing, Zhong, Wei, Liu, Xiaoyan, Gao, Xiaoxing, Li, Shanqing, Li, Ji, Guo, Chao, Jia, He, Wang, Mengzhao
Publicado 2022

Clinical features and outcomes of ALK rearranged non‐small cell lung cancer with primary resistance to crizotinib

por Ma, Di, Zhang, Yan, Xing, Puyuan, Hao, Xuezhi, Wang, Mengzhao, Wang, Yan, Shan, Li, Xin, Tao, Liang, Hongge, Du, Yang, Zhang, Zhaohui, Liang, Li, Li, Junling
Publicado 2019

Impact of crizotinib on long-term survival of ALK-positive advanced non-small-cell lung cancer: A Chinese multicenter cohort study

por Xing, Puyuan, Ma, Di, Wang, Qiang, Hao, Xuezhi, Wang, Mengzhao, Wang, Yan, Shan, Li, Xin, Tao, Liang, Li, Liang, Hongge, Du, Yang, Zhang, Zhaohui, Li, Junling
Publicado 2019

Real‐world data on EGFR/ALK gene status and first‐line targeted therapy rate in newly diagnosed advanced non‐small cell lung cancer patients in Northern China: A prospective observ...

por Liang, Hongge, Song, Xia, Zhang, Yuhui, Zhang, Shucai, Li, Fang, Fang, Jian, Li, Junling, Liang, Li, Nie, Ligong, Ma, Kewei, Zhang, Liangming, Wang, Xiaohong, Xu, Junjun, Wei, Yanxia, Wang, Jinghui, Song, Qi, Tian, Guangming, Mu, Yuxin, Gu, Yangchun, Yang, Lei, Sun, Ping, Zhong, Wei, Zhao, Jing, Xu, Yan, Chen, Minjiang, Wang, Mengzhao
Publicado 2019